NM_006412.4:c.514G>A
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_006412.4(AGPAT2):c.514G>A(p.Glu172Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,613,448 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006412.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital generalized lipodystrophy type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Berardinelli-Seip congenital lipodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal diabetes mellitusInheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006412.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AGPAT2 | NM_006412.4 | MANE Select | c.514G>A | p.Glu172Lys | missense | Exon 4 of 6 | NP_006403.2 | ||
| AGPAT2 | NM_001012727.2 | c.492+302G>A | intron | N/A | NP_001012745.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AGPAT2 | ENST00000371696.7 | TSL:1 MANE Select | c.514G>A | p.Glu172Lys | missense | Exon 4 of 6 | ENSP00000360761.2 | ||
| AGPAT2 | ENST00000472820.1 | TSL:1 | n.442G>A | non_coding_transcript_exon | Exon 2 of 4 | ||||
| AGPAT2 | ENST00000371694.7 | TSL:1 | c.492+302G>A | intron | N/A | ENSP00000360759.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250874 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461274Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 726928 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74342 show subpopulations
ClinVar
Submissions by phenotype
Congenital generalized lipodystrophy type 1 Pathogenic:2Other:1
not provided Pathogenic:1
The E172K variant in the AGPAT2 gene has been reported previously in the homozygous state in association with Berardinelli-Seip syndrome (Magré et al., 2003; Haghighi et al., 2012; Rostami et al., 2013). The E172K variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The E172K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret E172K as a likely pathogenic variant.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at